203 related articles for article (PubMed ID: 33065341)
1. Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional Dyspepsia.
Sarnelli G; Pesce M; Seguella L; Lu J; Efficie E; Tack J; Elisa De Palma FD; D'Alessandro A; Esposito G
Cell Mol Gastroenterol Hepatol; 2021; 11(3):841-855. PubMed ID: 33065341
[TBL] [Abstract][Full Text] [Related]
2. Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients With Functional Dyspepsia.
Wauters L; Ceulemans M; Frings D; Lambaerts M; Accarie A; Toth J; Mols R; Augustijns P; De Hertogh G; Van Oudenhove L; Tack J; Vanuytsel T
Gastroenterology; 2021 Apr; 160(5):1521-1531.e9. PubMed ID: 33346007
[TBL] [Abstract][Full Text] [Related]
3. Evidence of Duodenal Epithelial Barrier Impairment and Increased Pyroptosis in Patients With Functional Dyspepsia on Confocal Laser Endomicroscopy and "Ex Vivo" Mucosa Analysis.
Nojkov B; Zhou SY; Dolan RD; Davis EM; Appelman HD; Guo X; Jackson K; Sturm MB; Wang TD; Owyang C; Liu JJ; Chey WD
Am J Gastroenterol; 2020 Nov; 115(11):1891-1901. PubMed ID: 33156108
[TBL] [Abstract][Full Text] [Related]
4. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
[TBL] [Abstract][Full Text] [Related]
5. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia.
Vanheel H; Vicario M; Vanuytsel T; Van Oudenhove L; Martinez C; Keita ÅV; Pardon N; Santos J; Söderholm JD; Tack J; Farré R
Gut; 2014 Feb; 63(2):262-71. PubMed ID: 23474421
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of duodenal eosinophils and mast cells in adult patients with functional dyspepsia.
Wang X; Li X; Ge W; Huang J; Li G; Cong Y; Li F; Liu Z; Liu Z; Li Y; Yuan H
Ann Diagn Pathol; 2015 Apr; 19(2):50-6. PubMed ID: 25735567
[TBL] [Abstract][Full Text] [Related]
7. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors.
Costa B; Comelli F; Bettoni I; Colleoni M; Giagnoni G
Pain; 2008 Oct; 139(3):541-550. PubMed ID: 18602217
[TBL] [Abstract][Full Text] [Related]
8. Concentration of Glial Cell Line-Derived Neurotrophic Factor Positively Correlates with Symptoms in Functional Dyspepsia.
Tanaka F; Tominaga K; Fujikawa Y; Nagami Y; Kamata N; Yamagami H; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y; Arakawa T
Dig Dis Sci; 2016 Dec; 61(12):3478-3485. PubMed ID: 27718082
[TBL] [Abstract][Full Text] [Related]
9. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide.
Ambrosino P; Soldovieri MV; Russo C; Taglialatela M
Br J Pharmacol; 2013 Mar; 168(6):1430-44. PubMed ID: 23083124
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia.
Sarnelli G; Seguella L; Pesce M; Lu J; Gigli S; Bruzzese E; Lattanzi R; D'Alessandro A; Cuomo R; Steardo L; Esposito G
J Neuroinflammation; 2018 Mar; 15(1):94. PubMed ID: 29573741
[TBL] [Abstract][Full Text] [Related]
11. Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner.
Sarnelli G; D'Alessandro A; Iuvone T; Capoccia E; Gigli S; Pesce M; Seguella L; Nobile N; Aprea G; Maione F; de Palma GD; Cuomo R; Steardo L; Esposito G
PLoS One; 2016; 11(5):e0156198. PubMed ID: 27219328
[TBL] [Abstract][Full Text] [Related]
12. Duodenal low-grade inflammation and expression of tight junction proteins in functional dyspepsia.
Taki M; Oshima T; Li M; Sei H; Tozawa K; Tomita T; Fukui H; Watari J; Miwa H
Neurogastroenterol Motil; 2019 Oct; 31(10):e13576. PubMed ID: 30790378
[TBL] [Abstract][Full Text] [Related]
13. Duodenal intraepithelial T lymphocytes in patients with functional dyspepsia.
Gargala G; Lecleire S; François A; Jacquot S; Déchelotte P; Ballet JJ; Favennec L; Ducrotté P
World J Gastroenterol; 2007 Apr; 13(16):2333-8. PubMed ID: 17511033
[TBL] [Abstract][Full Text] [Related]
14. The Altered Mucosal Barrier Function in the Duodenum Plays a Role in the Pathogenesis of Functional Dyspepsia.
Komori K; Ihara E; Minoda Y; Ogino H; Sasaki T; Fujiwara M; Oda Y; Ogawa Y
Dig Dis Sci; 2019 Nov; 64(11):3228-3239. PubMed ID: 30673985
[TBL] [Abstract][Full Text] [Related]
15. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
Capasso R; Orlando P; Pagano E; Aveta T; Buono L; Borrelli F; Di Marzo V; Izzo AA
Br J Pharmacol; 2014 Sep; 171(17):4026-37. PubMed ID: 24818658
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of transient receptor potential vanilloid (TRPV) and down-regulation of brain-derived neurotrophic factor (BDNF) expression in patients with functional dyspepsia (FD).
Cheung CKY; Lan LL; Kyaw M; Mak ADP; Chan A; Chan Y; Wu JCY
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28782273
[TBL] [Abstract][Full Text] [Related]
17. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα.
Karwad MA; Macpherson T; Wang B; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
FASEB J; 2017 Feb; 31(2):469-481. PubMed ID: 27623929
[TBL] [Abstract][Full Text] [Related]
18. Duodenal mucosal secretory disturbances in functional dyspepsia.
Puthanmadhom Narayanan S; Linden DR; Peters SA; Desai A; Kuwelker S; O'Brien D; Smyrk TJ; Graham RP; Grover M; Bharucha AE
Neurogastroenterol Motil; 2021 Jan; 33(1):e13955. PubMed ID: 32776463
[TBL] [Abstract][Full Text] [Related]
19. Functional dyspepsia patients have lower mucosal cholecystokinin concentrations in response to duodenal lipid.
van Boxel OS; ter Linde JJ; Oors J; Otto B; Weusten BL; Feinle-Bisset C; Smout AJ; Siersema PD
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):205-12. PubMed ID: 24252886
[TBL] [Abstract][Full Text] [Related]
20. Sini San ameliorates duodenal mucosal barrier injury and low‑grade inflammation via the CRF pathway in a rat model of functional dyspepsia.
Zhu C; Zhao L; Zhao J; Zhang S
Int J Mol Med; 2020 Jan; 45(1):53-60. PubMed ID: 31746413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
